Market Access Strategy & HEOR Support

Delivered a comprehensive national market access roadmap supported by epidemiologic and policy evidence. The plan defined viable reimbursement channels, regulatory steps, and pricing strategy, allowing the client to prepare for product submission and targeted stakeholder dialogue.

12 weeks

• Conducted a market access feasibility assessment, mapping the healthcare and reimbursement system, orphan-drug regulations, and early-access opportunities.
• Performed epidemiological research and estimated the potential patient population and treatment flows for a rare oncohematology disease.
• Analyzed the current market structure, competitors, and procurement practices in the hematology segment.
• Prepared a strategic market access plan, including pricing and reimbursement scenarios, risk analysis, and implementation roadmap.
• Supported stakeholder mapping and interview preparation covering authorities, clinicians, and patient groups.
• Advised on economic modelling requirements, identifying data inputs for cost-effectiveness and budget-impact analyses.

The client required comprehensive market access and HEOR consulting support for introducing an innovative hematology therapy to the Ukrainian market. The objective was to design a feasible access pathway, define pricing and reimbursement options, and provide analytical evidence to guide strategic decisions and stakeholder engagement.